
Acquired Immune Deficiency Syndrome (AIDS) was first described in 1981 by University of California scientists who were researching the growing numbers of gay men dying from unusual cancers and strange infections. Two years later, the cause of AIDS was identified: human immunodeficiency virus (HIV), a retrovirus that destroys the immune system’s white blood cells, leaving the victim unable to fight off everyday infections and disease. Without treatment, AIDS is invariably fatal.
Over 40.4 million people worldwide have died from AIDS since that time, including 700,000 in the United States. An estimated 1.2 million Americans are currently living with HIV, 105,000 in New York state. But the annual infection rate has dropped by more than two-thirds since the height of the AIDS epidemic in the 1980s, and it continues to slowly decline at 39,000 new HIV cases yearly — largely due to the CDC’s HIV prevention initiative, which funds testing, treatment, and patient education. Thanks to advances in medication, AIDS-related annual deaths have had a nine-fold drop, to 19,000 (one-10th of those are in New York).
HIV is spread through contact with infected blood, semen, and vaginal and rectal fluids — most commonly through unprotected sex (not using a condom) or contaminated needles. It cannot be caught, as some believe, by donating blood, touching toilet seats, or sharing cups and utensils.
Those at highest risk for HIV include men who have sex with men, comprising 67% of victims. Black and Latino people are disproportionately affected, due to factors such as poverty and limited access to health care.
It takes two to four weeks to develop symptoms after being exposed to HIV. Without treatment, the infection progresses through three stages, which takes an average of 13 years.
The first (acute) stage is the most contagious, and lasts up to a month. In this time, HIV invades and destroys CD4 cells, the immune system’s white blood corpuscles that fight infection and disease. The victim may experience flu-like symptoms, such as fever, chills, and muscle aches — or have no symptoms at all.
The second (chronic) stage lasts up to 10 years: the virus is still multiplying and killing CD4 cells, but more slowly. Many victims feel healthy during this time, but they are still contagious.
AIDS is the final stage of an HIV infection: The CD4 cell count plummets, which results in a dysfunctional immune system. Sufferers typically develop extreme fatigue, night sweats, or rapid weight loss. They can be overwhelmed by opportunistic infections, known as AIDS-defining illnesses — diseases that a normal immune system can fight off. For example, yeast can cause a mild throat infection (thrush) in a healthy person, but it often spreads to the liver, kidneys, and brain of an AIDS victim. Most victims die within three years of being diagnosed with AIDS.

There is no cure for HIV, but treatment with antiretroviral therapy (ART) — available as multiple- or single-tablet regimens — reduces the viral load in the body so the immune system works properly again, and the sufferer is no longer contagious. More than 90% of people who take ART have undetectable levels of HIV by blood test within 12 months. A study published in the May 2023 Lancet showed that people who start treatment immediately after their diagnosis can have a normal life span. Side effects of ART vary and are sometimes serious. Medication must be taken consistently for a lifetime, or HIV can recur.
Wearing condoms is an important way to help prevent HIV; people who inject drugs should not share needles. There are also two regimens (using prescription antiretroviral medication) to help prevent HIV. Post-exposure prophylaxis (PEP), must be started within 72 hours after HIV exposure, then taken for 28 days. It is 80% effective. Pre-exposure prophylaxis (PrEP) is prescribed to those at high risk for infection: Pills are taken before and after a possible HIV sexual exposure, and are 99% effective.
The U.S. Preventive Services Task Force recommends that anyone between ages 15 and 65 take an HIV test at least once in their lifetime. Anyone at risk may benefit from testing every three to six months. In-home OTC tests like OraQuick are over 95% accurate.
According to the American Foundation for AIDS Research (amFAR), the average lifetime case of HIV treatment is $420,000. Without coverage, one course of PEP costs $1,000; monthly PrEP costs $60 for generic medication, $2,000 for brand. Medicaid is the largest source of insurance coverage for people with HIV, providing a broad range of services and medication to an estimated 40% of non-elderly sufferers. Programs like the federally-subsidized Ryan White HIV/AIDS Program supply low-cost treatment to the underinsured.
The HIV + Hepatitis Policy Institute predicted that the current administration’s proposed cuts of over $800 million to the CDC’s Division of HIV Prevention’s $1 billion budget — an 80% drop — will significantly increase the numbers of new HIV cases and AIDS-related deaths in the U.S. According to amFAR estimates, even a 50% budgetary cut would result in 75,000 more infections and 7,500 more deaths by 2030.
What’s more, a study published in the April 2025 Lancet found that the administration’s plans to defund the President’s Emergency Plan for AIDS Relief (PEPFAR) — which provides global HIV/AIDS services and treatment — could cause nearly 3 million additional deaths by 2030 across 26 countries.
Exposure to HIV is a medical emergency: Call your primary care provider immediately, go to the nearest emergency room, or call the New York state PEP hotline at 844-373-7692.
More information about HIV/AIDS can be found at the New York State Department of Health website. Dutchess County’s Family Partnership Center in Poughkeepsie and Columbia County Department of Health’s STD clinic in Hudson provide low-cost HIV testing and treatment — including PEP and PrEP, and outreach services.
Dr. Mary Jenkins, a contributor to the Herald and member of its board of directors, retired after nearly 40 years as a family practice physician in New York state.

